Cited by 865Healthcare Systems and Public HealthCardiovascular Health and Risk FactorsGlobal Health and Epidemiology

Mortality From Ischemic Heart Disease: Analysis of Data From the World Health Organization and Coronary Artery Disease Risk Factors From NCD Risk Factor Collaboration

Open access
Nowbar, Alexandra N., Gitto, Mauro, Howard, James P., Francis, Darrel P., Al-Lamee, Rasha·2019·Circulation: Cardiovascular Quality and Outcomes

Abstract

Background: Ischemic heart disease (IHD) has been considered the top cause of mortality globally. However, countries differ in their rates and there have been changes over time. Methods and Results: We analyzed mortality data submitted to the World Health Organization from 2005 to 2015 by individual countries. We explored patterns in relationships with age, sex, and income and calculated age-standardized mortality rates for each country in addition to crude death rates. In 5 illustrative countries which provided detailed data, we analyzed trends of mortality from IHD and 3 noncommunicable diseases (lung cancer, stroke, and chronic lower respiratory tract diseases) and examined the simultaneous trends in important cardiovascular risk factors. Russia, United States, and Ukraine had the largest absolute numbers of deaths among the countries that provided data. Among 5 illustrative countries (United Kingdom, United States, Brazil, Kazakhstan, and Ukraine), IHD was the top cause of death, but mortality from IHD has progressively decreased from 2005 to 2015. Age-standardized IHD mortality rates per 100 000 people per year were much higher in Ukraine (324) and Kazakhstan (97) than in United States (60), Brazil (54), and the United Kingdom (46), with much less difference in other causes of death. All 5 countries showed a progressive decline in IHD mortality, with a decline in smoking and hypertension and in all cases a rise in obesity and type II diabetes mellitus. Conclusions: IHD remains the single largest cause of death in countries of all income groups. Rates are different between countries and are falling in most countries, indicating great potential for further gains. On the horizon, future improvements may become curtailed by increasing hypertension in some developing countries and more importantly global growth in obesity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circoutcomes.118.005375

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MI and ischemic cardiomyopathy are among the leading causes of heart failure, associated morbidity, and death worldwide and continue to impose staggering financial burden on healthcare systems.

    “Despite advancements in clinical management, MI and ischemic cardiomyopathy are among the leading causes of heart failure, associated morbidity, and death worldwide 3,4 and continue to impose staggering financial burden on healthcare systems 3,5-8 .”

    From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [5]

    The Discussion’s Conclusions state that ischemic heart disease remains the leading cause of death across income groups, supporting the worldwide mortality portion. The paper does not establish that MI and ischemic cardiomyopathy are leading causes of heart failure or associated morbidity, or that they impose a staggering financial burden on healthcare systems; its discussion of economic conditions does not make that claim. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nowbar, A. N., Gitto, M., Howard, J. P., Francis, D. P., & Al-Lamee, R.
Affiliations
  • Hammersmith Hospital (GB)
  • International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, United Kingdom (A.N.N., M.G., J.P.H., D.P.F., R.A.-L.).
Corresponding author
Nowbar, Alexandra N.
Venue
Circulation: Cardiovascular Quality and Outcomes
Published
2019-06
Volume
12
Issue
6
Pages
e005375-e005375
ISSN
  • 1941-7705 (ISSN-L)
  • 1941-7713
OpenAlex
W2950663303
Cited by
860
References
20
Citations by year
2026: 58 · 2025: 121 · 2024: 149 · 2023: 155 · 2022: 147 · 2021: 133 · 2020: 83 · 2019: 12 · 2017: 1 · 2016: 1
FWCI
71.55
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Circulation Cardiovascular Quality and Outcomes (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (212183/Z/18/Z)
  • National Institute for Health and Care Research
Topics
  • Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Health Professions › Health Information Management › Global Health and Epidemiology
Keywords
ischemic heart disease, mortality trends, age-standardized mortality rates, non-communicable diseases, lung cancer, stroke, cardiovascular risk factors, smoking, hypertension, obesity, type 2 diabetes, income inequality, sex differences, global burden of disease
MeSH terms
Adult, Aged, Aged, 80 and over, Cause of Death, Diabetes Mellitus, Female, Humans, Hypertension, Male, Middle Aged, Obesity, Risk Factors, Smoking, Time Factors, Global Health, World Health Organization, Comorbidity, Prevalence, Myocardial Ischemia, Age Distribution, Sex Distribution, Risk Assessment, Health Status Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review